Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Kangzhe Biotechnology
Shenzhen, Guangdong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Shenzhen Kangzhe Biotech has a diversified pipeline with at least nine clinical trials across multiple therapeutic areas including immune system disorders and metabolic disease. The company works with small molecules, peptides, monoclonal antibodies—including licensed assets such as tildrakizumab—and novel modalities like non-degrading molecular glues. Some programs have achieved regulatory approval internationally through partnerships or licensing arrangements.
- Therapeutic areas
- NeurologyInfectious DiseasesDermatologyOphthalmologyGastroenterologyEndocrinologyHematologyOncologyImmunology
- Modalities
- Small molecule drugSynthetic peptideNon-degrading molecular glueMonoclonal antibody
- Industry
- Biotech
02
Partnerships
Licensing relationships with international pharma companies for certain products/assets—e.g., tildrakizumab originated from Merck Sharp & Dohme Corp.; difluprednate from Mitsubishi Tanabe Pharma Corp.
Beyond the preview
Go deeper on Shenzhen Kangzhe Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Kangzhe Biotechnology.